EUVIMEDEUVIMED entdecken
Open Access

Early-Frame [ 18 F]Florbetaben PET/MRI for Cerebral Blood Flow Quantification in Patients with Cognitive Impairment: Comparison to an [ 15 O]Water Gold Standard

Ates Fettahoglu, Moss Zhao, Mehdi Khalighi, Hillary Vossler, Maria Jovin, Guido Davidzon, Michael Zeineh, Fernando Boada, Elizabeth Mormino, Victor W Henderson, Michael Moseley, Kevin T Chen und 1 weitere

Journal of Nuclear Medicine · 2024-02 · 65 (2) · 306-312

DOI: 10.2967/jnumed.123.266273 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nuclear Medicine, online erschienen am 07.12.2023. Verfasst von Ates Fettahoglu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Stanford University, Stanford, California. Hauptthemen laut MEDLINE: Dementia, Cognitive Dysfunction, Aniline Compounds, Stilbenes. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIBIB NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cerebral blood flow (CBF) may be estimated from early-frame PET imaging of lipophilic tracers, such as amyloid agents, enabling measurement of this important biomarker in participants with dementia and memory decline. Although previous methods could map relative CBF, quantitative measurement in absolute units (mL/100 g/min) remained challenging and has not been evaluated against the gold standard method of [15O]water PET. The purpose of this study was to develop and validate a minimally invasive quantitative CBF imaging method combining early [18F]florbetaben (eFBB) with phase-contrast MRI using simultaneous PET/MRI.

Methods

Twenty participants (11 men and 9 women; 8 cognitively normal, 9 with mild cognitive impairment, and 3 with dementia; 10 β-amyloid negative and 10 β-amyloid positive; 69 ± 9 y old) underwent [15O]water PET, phase-contract MRI, and eFBB imaging in a single session on a 3-T PET/MRI scanner. Quantitative CBF images were created from the first 2 min of brain activity after [18F]florbetaben injection combined with phase-contrast MRI measurement of total brain blood flow. These maps were compared with [15O]water CBF using concordance correlation (CC) and Bland-Altman statistics for gray matter, white matter, and individual regions derived from the automated anatomic labeling (AAL) atlas.

Results

The 2 methods showed similar results in gray matter ([15O]water, 55.2 ± 14.7 mL/100 g/min; eFBB, 55.9 ± 14.2 mL/100 g/min; difference, 0.7 ± 2.4 mL/100 g/min; P = 0.2) and white matter ([15O]water, 21.4 ± 5.6 mL/100 g/min; eFBB, 21.2 ± 5.3 mL/100 g/min; difference, -0.2 ± 1.0 mL/100 g/min; P = 0.4). The intrasubject CC for AAL-derived regions was high (0.91 ± 0.04). Intersubject CC in different AAL-derived regions was similarly high, ranging from 0.86 for midfrontal regions to 0.98 for temporal regions. There were no significant differences in performance between the methods in the amyloid-positive and amyloid-negative groups as well as participants with different cognitive statuses.

Conclusion

We conclude that eFBB PET/MRI can provide robust CBF measurements, highlighting the capability of simultaneous PET/MRI to provide measurements of both CBF and amyloid burden in a single imaging session in participants with memory disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DementiaCognitive DysfunctionAniline CompoundsStilbenesMaleHumansFemaleWaterOxygen RadioisotopesPositron-Emission TomographyMagnetic Resonance ImagingCerebrovascular CirculationBrain

Stichwörter der Autor:innen

PET/MRI[18F]florbetaben PETcerebral blood flowphase-contrast MRI

Substanzen

4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbeneWaterOxygen RadioisotopesAniline CompoundsStilbenes

Autor:innen und Institutionen

  • Department of Radiology, Stanford University, Stanford, California.
  • Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Connecticut.
  • Stanford Cardiovascular Institute, Stanford University, Stanford, California.
  • Department of Neurology and Neurological Sciences, Stanford University, Stanford, California; and.
  • Department of Biomedical Engineering, National Taiwan University, Taipei, Taiwan chenkt@ntu.edu.tw.

Förderung

  • NIA NIH HHS
  • NIBIB NIH HHS

Zitieren

APA

Fettahoglu, A., Zhao, M., Khalighi, M., Vossler, H., Jovin, M., Davidzon, G., Zeineh, M., Boada, F., Mormino, E., Henderson, V. W., Moseley, M., Chen, K. T., & Zaharchuk, G. (2024). Early-Frame [ 18 F]Florbetaben PET/MRI for Cerebral Blood Flow Quantification in Patients with Cognitive Impairment: Comparison to an [ 15 O]Water Gold Standard. Journal of Nuclear Medicine, 65(2), 306-312. https://doi.org/10.2967/jnumed.123.266273

Vancouver

Fettahoglu A, Zhao M, Khalighi M, Vossler H, Jovin M, Davidzon G, et al. Early-Frame [ 18 F]Florbetaben PET/MRI for Cerebral Blood Flow Quantification in Patients with Cognitive Impairment: Comparison to an [ 15 O]Water Gold Standard. Journal of Nuclear Medicine. 2024;65(2):306-312. doi:10.2967/jnumed.123.266273

BibTeX
@article{Fettahoglu2024,
  author = {Fettahoglu, Ates and Zhao, Moss and Khalighi, Mehdi and Vossler, Hillary and Jovin, Maria and Davidzon, Guido and Zeineh, Michael and Boada, Fernando and Mormino, Elizabeth and Henderson, Victor W and Moseley, Michael and Chen, Kevin T and Zaharchuk, Greg},
  title = {Early-Frame [ 18 F]Florbetaben PET/MRI for Cerebral Blood Flow Quantification in Patients with Cognitive Impairment: Comparison to an [ 15 O]Water Gold Standard},
  journal = {Journal of Nuclear Medicine},
  year = {2024},
  volume = {65},
  number = {2},
  pages = {306--312},
  doi = {10.2967/jnumed.123.266273}
}
Kostenlos starten →